Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial

Table 4 Reliability of outcome measures

Reliability		r	ICC
Isometric strength	Hip extension (Nm)	0.74	0.85
	Hip flexion (Nm)	0.92	0.96
	Knee extension (Nm)	0.94	0.96
	Knee flexion (Nm)	0.95	0.97
	Ankle plantarflexion (Nm)	0.92	0.94
	Ankle dorsiflexion (Nm)	0.91	0.96
Gait
Spatiotemporal metrics	Cadence (steps/min)	0.97	0.98
	Gait speed (m/s)	0.86	0.93
	Foot strike angle (degrees)	0.93	0.96
	Stance (%)	0.97	0.99
	Stride length (m)	0.95	0.98
	Swing (%)	0.97	0.99
Kinematics	Hip flexion (degrees)	0.70	0.82
	Hip extension (degrees)	0.70	0.82
	Knee flexion (degrees)	0.71	0.77
	Knee extension (degrees)	0.82	0.86
	Ankle plantarflexion (degrees)	0.94	0.95
	Ankle dorsiflexion (degrees)	0.93	0.93
Balance	Composite equilibrium score (%)	0.87	0.67

ISSN: 1745-6215